Daniel Van Plew
2009
In 2009, Daniel Van Plew earned a total compensation of $1.6M as Senior Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals.
Compensation breakdown
| Bonus | $232,338 |
|---|---|
| Option Awards | $967,702 |
| Salary | $337,700 |
| Other | $13,540 |
| Total | $1,551,280 |
Van Plew received $967.7K in option awards, accounting for 62% of the total pay in 2009.
Van Plew also received $232.3K in bonus, $337.7K in salary and $13.5K in other compensation.
Rankings
In 2009, Daniel Van Plew's compensation ranked 3,077th out of 9,885 executives tracked by ExecPay. In other words, Van Plew earned more than 68.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,077 out of 9,885 | 69th |
Division Manufacturing | 1,077 out of 3,690 | 71st |
Major group Chemicals And Allied Products | 209 out of 866 | 76th |
Industry group Drugs | 121 out of 638 | 81st |
Industry Pharmaceutical Preparations | 98 out of 446 | 78th |
Source: SEC filing on April 26, 2010.
Van Plew's colleagues
We found four more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2009.
2009
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2009
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2009
Neil Stahl
Regeneron Pharmaceuticals
Senior Vice President, Research & Development Sciences
2009
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019